GHADEER SUAIFAN | Pharmaceutical Sciences | Best Researcher Award

Posted on by ScienceFather

Prof GHADEER SUAIFAN | Pharmaceutical Sciences | Best Researcher Award

Research Scholar, The University of Jordan, Jordan

Ghadeer A. Suaifan was born in December 1973 and is a Jordanian national. She is fluent in both Arabic and English. Ghadeer holds a PhD and an MPhil in Medicinal Chemistry and Instrumental Analysis from the University of Bath, UK, and a BSc (Honours) in Pharmacy from Petra University, Jordan. She currently serves as a Professor of Medicinal Chemistry and Pharmaceutical Instrumental Analysis at the Faculty of Pharmacy, The University of Jordan. Her research interests span medicinal chemistry, nanotechnology, and public health, with significant contributions in optimizing antidiabetic candidates, cancer treatments, and developing advanced analytical techniques. Ghadeer has published extensively and holds several patents.

Profile

Education🎓

From 2001 to 2004, Ghadeer A. Suaifan pursued a PhD in Medicinal Chemistry and Instrumental Analysis at the Department of Pharmacy and Pharmacology, University of Bath, UK. Prior to this, she completed an MPhil in Medicinal Chemistry and Instrumental Analysis at the same institution from 2000 to 2001. Ghadeer began her academic journey with a BSc (Honours) in Pharmacy from the College of Pharmacy, Petra University, Amman, Jordan, which she completed between 1991 and 1996. Her foundational education was acquired at Al-Room Al-Catholic School in Zarka, Jordan, where she earned her General Secondary Education Certificate from 1988 to 1991.

Experience 🏢

Prof. Ghadeer Suaifan is a distinguished Professor of Medicinal Chemistry and Pharmaceutical Instrumental Analysis at the Faculty of Pharmacy, The University of Jordan, where she has been serving since September 2016. In this role, she leads advanced research and teaching, significantly contributing to the academic and research excellence of the institution. Prior to this, she held the position of Associate Professor from September 2012 to September 2016, during which she focused on enhancing the curriculum and advancing research initiatives in medicinal chemistry and pharmaceutical sciences. From 2005 to 2012, Prof. Suaifan worked as an Assistant Professor at the same faculty, delivering undergraduate and postgraduate courses in pharmaceutical sciences and engaging in significant research activities. Additionally, she served as an Assistant Professor at the Faculty of Pharmacy, Philadelphia University, Amman, Jordan, from 2004 to 2005, where she contributed to the development of pharmaceutical education and research. Prof. Suaifan’s extensive experience and dedication have made her a vital asset to the field of pharmaceutical sciences in Jordan.

Research Interests 🔬

Ghadeer’s research encompasses Medicinal Chemistry and Instrumental Analysis, focusing on optimizing new antidiabetic candidates, elucidating molecular structures, and developing advanced prodrug systems for prostate cancer. Her work extends to Nanotechnology, including biological particle detection, miniaturized instrumentation, and medical diagnostics. She also investigates Public Research, evaluating antibiotic use behaviors and the prevalence of Complementary and Alternative Medicine in Jordan.

Special Awards 🏆

Professor Ghadeer Suaifan has been recognized for her outstanding contributions to research and development. She received the prestigious Ibtikar Award from Mewiin, Kuwait, in 2020. Her dedication to scientific research was further acknowledged with the Samia Mango Award from the Hamdi Mango Center for Scientific Research in Amman, Jordan, in 2018. In 2015, she was honored with the Excellent Oral Presenter Award at the International Conference on Pharmaceutical Sciences (ICPS) held in Dubai. Professor Suaifan’s academic achievements were consistently recognized during her time at the Faculty of Pharmacy, Petra University, where she received University Awards for Best Achievement from 1991 to 1996. In addition to her accolades, she has been a Registered Pharmacist with the Jordanian Pharmacists Association in Amman since January 1996, showcasing her longstanding commitment to the pharmaceutical profession and her continuous contributions to the field.

Publications Top Notes 📚

  1. Magnetic beads-based nanozyme for portable colorimetric biosensing of Helicobacter pylori
    • Authors: Suaifan, G.A.R.Y., Shehadeh, M.B., Darwish, R.M., Alaridah, N., Zourob, M.
    • Year: 2024
    • Journal: Biosensors and Bioelectronics: X, Volume 20, Article 100517
  2. Rapid Colorimetric Quantitative Portable Platform for Detection of Brucella melitensis Based on a Fluorescence Resonance Energy Transfer Assay and Nanomagnetic Particles
    • Authors: Alhogail, S., Chinnappan, R., Suaifan, G.A., Jürgen, P., Zourob, M.M.
    • Year: 2024
    • Journal: ACS Omega, Volume 9, Issue 19, Pages 20997–21005
  3. A cross-sectional study on adult lifestyle habits during the COVID-19 pandemic
    • Authors: Suaifan, G.A.R.Y., Abu-Odeh, A.M., Shehadeh, M.B., Jbara, W.A., Nassar, R.I.
    • Year: 2024
    • Journal: PLoS ONE, Volume 19, Issue 5, Article e0299668
  4. Synthesis, urease inhibitory and anticancer evaluation of glucosamine-sulfonylurea conjugates
    • Authors: Suaifan, G.A.R.Y., Shehadeh, M., Tahboub, D., Gaurav, A., Khan, M.
    • Year: 2024
    • Journal: Medicinal Chemistry Research, Volume 33, Issue 4, Pages 663–676
  5. Glucosamine substituted sulfonylureas: IRS-PI3K-PKC-AKT-GLUT4 insulin signalling pathway intriguing agent
    • Authors: Suaifan, G.A.R.Y., Alkhawaja, B., Shehadeh, M.B., Hor Kuan, C., Okechukwu, P.N.
    • Year: 2024
    • Journal: RSC Medicinal Chemistry, Volume 15, Issue 2, Pages 695–703
  6. Development of Rapid Aptamer-Based Screening Assay for the Detection of Covid-19 Variants
    • Authors: Aloraij, Y.M., Suaifan, G.A.R.Y., Shibl, A., Al-Kattan, K., Zourob, M.M.
    • Year: 2023
    • Journal: ACS Omega, Volume 8, Issue 36, Pages 32877–32883
  7. Medicinal plants of Jordan: Scoping review
    • Authors: Abu-Odeh, A., Fino, L., Al-Absi, G., Shehadeh, M., Suaifan, G.
    • Year: 2023
    • Journal: Heliyon, Volume 9, Issue 6, Article e17081
  8. Antibiotic—Lysobacter enzymogenes proteases combination as a novel virulence attenuating therapy
    • Authors: Suaifan, G.A.R.Y., Abdel Rahman, D.M.A., Abu-Odeh, A.M., Shehadeh, M.B., Darwish, R.M.
    • Year: 2023
    • Journal: PLoS ONE, Volume 18, Issue 3, Article e0282705
  9. Knowledge, practice and attitude associated with SARS-CoV-2 Delta Variant among adults in Jordan
    • Authors: Suaifan, G.A.R.Y., Abu-Odeh, A.M., Shehadeh, M.B., Shahwan, M., Jbara, F.A.
    • Year: 2022
    • Journal: PLoS ONE, Volume 17, Issue 12, Article e0278243

 

 

Giovanna Rassu | Toxicology and Pharmaceutical Science | Women Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Giovanna Rassu | Toxicology and Pharmaceutical Science | Women Researcher Award

Associate Professor at University of Sassari, Italy.

Dr. Giovanna Rassu is an accomplished Associate Professor in Pharmaceutical Technology with over 10 years of academic experience. She holds a Ph.D. in Pharmaceutical, Food, and Cosmetic Sciences and has undergone specialized training in biotechnology and pharmaceutical development. Throughout her career, Dr. Rassu has conducted extensive research focused on designing and characterizing novel drug delivery systems for the treatment of various diseases, including cancer and neurodegenerative disorders. Her expertise encompasses in-vitro and ex-vivo characterization techniques, and she has a strong publication record with numerous citations. Dr. Rassu is an active participant in academic conferences and workshops, where she shares her insights on drug delivery advancements. Additionally, she serves as an editorial board member and reviewer for several scientific journals and holds memberships in prestigious professional organizations. Dr. Rassu’s contributions to the field of pharmaceutical technology have been recognized with awards, including the “Women in Nanoscience Award.” Overall, her dedication to research, teaching, and academic leadership underscores her significant impact on advancing pharmaceutical sciences.

Professional Profiles:

Education

Associate Professor Dr. Giovanna Rassu boasts a rich educational background, culminating in a Ph.D. in Pharmaceutical, Food, and Cosmetic Sciences from the University of Genoa, which she completed between January 2004 and December 2006. Her doctoral journey concluded on April 20, 2007, marking a significant milestone in her academic career. Prior to this, she pursued a Master II Level program in Pre-formulation, Pharmaceutical Development, and Drug Control at the University of Pavia from March 2008 to October 2008, earning her diploma on October 22, 2008. Additionally, Dr. Rassu completed a Training Course of Technologies Applied to Biotechnology at Porto Conte Ricerche, Alghero, Italy, from September 2009 to January 2010. Her educational journey began with a Master’s Degree in Pharmaceutical Chemistry and Technology at the University of Sassari, where she graduated with distinction, scoring 110/110 with praise, from October 1997 to March 2003. She commenced her academic pursuits with a High School Diploma from the National teacher’s college “Margherita di Castelvì”, Sassari, where she excelled with a perfect score of 60/60 from September 1992 to June 1997. Through these educational endeavors, Dr. Rassu laid a solid foundation for her subsequent achievements and contributions in the field of pharmaceutical technology.

Professional Experience

Dr. Giovanna Rassu has amassed a wealth of professional experience in the pharmaceutical field, spanning both academic and research roles. Since November 1st, 2018, she has served as an Associate Professor in Pharmaceutical Technology at the Department of Medical, Surgical, and Experimental Sciences at the University of Sassari. Prior to this, from May 16th, 2011, to October 3rd, 2018, Dr. Rassu held the position of Researcher in Pharmaceutical Technology at the Department of Chemistry and Pharmacy, also at the University of Sassari. Her academic journey began as a Research Fellow at the Department of Pharmaceutical Sciences of the University of Sassari, where she contributed to the development of research projects funded by Banco di Sardegna Bank from July 1st, 2009, to May 15th, 2011, and from May 2nd, 2007, to May 2nd, 2009. Throughout her tenure, Dr. Rassu has exhibited dedication and expertise, making significant contributions to the advancement of pharmaceutical technology and drug delivery systems.

Research Interest

Dr. Giovanna Rassu’s research interests primarily focus on the design, preparation, and characterization of novel drug delivery systems for various routes of administration. Specifically, she is interested in developing drug delivery systems intended for the treatment of diseases such as cancer and neurodegenerative disorders. Her research endeavors also encompass the in-vitro and ex-vivo characterization of these delivery systems, with a particular emphasis on nasal formulations for systemic administration and brain targeting of therapeutics. Through her work, Dr. Rassu aims to advance the field of pharmaceutical technology and contribute to the development of more effective and targeted drug delivery strategies.

Award and Honors

Dr. Giovanna Rassu has been recognized for her exemplary contributions to the field of nanoscience, receiving the prestigious “WOMEN IN NANOSCIENCE AWARD” at the Global Conference on Nanotechnology. This award underscores her significant achievements and leadership in advancing research and innovation within the nanoscience community. It highlights her dedication and impact in pushing the boundaries of knowledge and fostering advancements in drug delivery and pharmaceutical technology.

Research Skills

Dr. Giovanna Rassu possesses a diverse range of research skills that have contributed to her success in the field of pharmaceutical technology. Her expertise includes the design, preparation, and characterization of novel drug delivery systems for various routes of administration, with a focus on treating diseases such as cancer and neurodegenerative disorders. She is proficient in in-vitro and ex-vivo characterization techniques, allowing for thorough assessment of drug delivery system performance. Additionally, Dr. Rassu demonstrates strong analytical skills in interpreting research data and drawing meaningful conclusions. Her research skills are complemented by her ability to collaborate effectively with multidisciplinary teams and her commitment to staying updated with the latest advancements in the field.

Publications

  1. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies
    • Authors: E Gavini, AB Hegge, G Rassu, V Sanna, C Testa, G Pirisino, J Karlsen, …
    • Year: 2006
    • Citations: 239
  2. Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapy
    • Authors: G Rassu, E Soddu, AM Posadino, G Pintus, B Sarmento, P Giunchedi, …
    • Year: 2017
    • Citations: 194
  3. Nanoemulsions for “nose-to-brain” drug delivery
    • Authors: MC Bonferoni, S Rossi, G Sandri, F Ferrari, E Gavini, G Rassu, …
    • Year: 2019
    • Citations: 187
  4. Indocyanine green delivery systems for tumour detection and treatments
    • Authors: EP Porcu, A Salis, E Gavini, G Rassu, M Maestri, P Giunchedi
    • Year: 2016
    • Citations: 161
  5. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies
    • Authors: V Sanna, E Gavini, M Cossu, G Rassu, P Giunchedi
    • Year: 2007
    • Citations: 146
  6. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies
    • Authors: E Gavini, G Rassu, V Sanna, M Cossu, P Giunchedi
    • Year: 2005
    • Citations: 144
  7. Solid microparticles based on chitosan or methyl-β-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate
    • Authors: G Rassu, E Soddu, M Cossu, A Brundu, G Cerri, N Marchetti, L Ferraro, …
    • Year: 2015
    • Citations: 140
  8. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide
    • Authors: E Gavini, G Rassu, C Muzzarelli, M Cossu, P Giunchedi
    • Year: 2008
    • Citations: 125
  9. Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases
    • Authors: G Rassu, A Salis, EP Porcu, P Giunchedi, M Roldo, E Gavini
    • Year: 2016
    • Citations: 107
  10. Preparation, In Vitro Characterization and Preliminary In Vivo Evaluation of Buccal Polymeric Films Containing Chlorhexidine
    • Authors: C Juliano, M Cossu, P Pigozzi, G Rassu, P Giunchedi
    • Year: 2008
    • Citations: 98